Inside these posts: Blood pressure

Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.


FDA approves Takeda blood pressure drug

Takeda Pharmaceuticals North America Inc.  in April will begin selling a new pill to treat high blood pressure after the  Food and Drug Administration approved the Deerfield-based company’s Edarbi tablets, the agency said.

Edarbi, which will cost about $75 for a month’s supply, enters a crowded field of blood pressure medications, including several cheaper generics that employers and consumer groups say work well and can cost pennies a day. Get the full story »